USPH Reports Third Quarter 2026 Results, Record High Visits and Revenue Per Visit
USPH reported Q3 2026 total net revenue of $223 million, up 13% year-over-year, on record patient visits of 1.7 million and revenue per visit of $111. Adjusted EPS rose to $0.80 from $0.66 and adjusted EBITDA climbed to $28 million from $24 million, but GAAP results showed a loss per share of $1.04 due to noncontrolling-interest revaluation mechanics rather than operations. The 72 hospital-affiliated clinics generated $25 million of quarterly revenue, and management expects this to grow as referral volumes and the affiliation pipeline expand.
Key figures
- Revenue
- 222558000
- Guidance
- FY2026 adjusted EBITDA of $102 million to $106 million reaffirmed
- Revenue Yoy
- 13%
- Cash
- 38225000
- Visits yoy
- 8.3%
- Ytd revenue
- 634902000
- Adjusted eps
- 0.8
- Location count
- 799
- Patient visits
- 1682642
- Adjusted ebitda
- 27781000
- Ytd revenue yoy
- 10%
- Revenue per visit
- 110.61
- Dividend per share
- 0.46
- Adjusted net income
- 11953000
- Ytd adjusted ebitda
- 74976000
- Net income prior year
- 13138000
- Adjusted eps prior year
- 0.66
- Adjusted ebitda prior year
- 23855000
- Credit facility borrowings
- 247000000
- Hospital affiliation clinics
- 72
- Hospital affiliation revenue
- 25039000
- Net income attributable to usph
- 11045000
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.